Novoste completes radioactive catheter recruitment
This article was originally published in Clinica
Executive Summary
Novoste has completed patient recruitment for its radioactive anti-restenosis study. The feasibility study will follow 23 patients for six months to see whether radiation treatment with the King Beta-Cath system reduced restenosis after balloon angioplasty.